Global Tuberculosis Diagnostic Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis Diagnostic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Radiographic Method
1.2.3 Diagnostic Laboratory Methods
1.2.4 Nucleic Acid Testing
1.2.5 Phage Assay
1.2.6 Detection of Latent Infection
1.2.7 Cytokine Detection Assay
1.2.8 Detection of Drug Resistance
1.3 Market by Application
1.3.1 Global Tuberculosis Diagnostic Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Infants
1.3.3 Adults
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Tuberculosis Diagnostic Market Size (2017-2028)
2.2 Tuberculosis Diagnostic Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Tuberculosis Diagnostic Market Size by Region (2017-2022)
2.4 Global Tuberculosis Diagnostic Market Size Forecast by Region (2023-2028)
2.5 Global Top Tuberculosis Diagnostic Countries Ranking by Market Size
3 Tuberculosis Diagnostic Competitive by Company
3.1 Global Tuberculosis Diagnostic Revenue by Players
3.1.1 Global Tuberculosis Diagnostic Revenue by Players (2017-2022)
3.1.2 Global Tuberculosis Diagnostic Market Share by Players (2017-2022)
3.2 Global Tuberculosis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Tuberculosis Diagnostic Revenue
3.4 Global Tuberculosis Diagnostic Market Concentration Ratio
3.4.1 Global Tuberculosis Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnostic Revenue in 2021
3.5 Global Tuberculosis Diagnostic Key Players Head office and Area Served
3.6 Key Players Tuberculosis Diagnostic Product Solution and Service
3.7 Date of Enter into Tuberculosis Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Tuberculosis Diagnostic Breakdown Data by Type
4.1 Global Tuberculosis Diagnostic Historic Revenue by Type (2017-2022)
4.2 Global Tuberculosis Diagnostic Forecasted Revenue by Type (2023-2028)
5 Global Tuberculosis Diagnostic Breakdown Data by Application
5.1 Global Tuberculosis Diagnostic Historic Market Size by Application (2017-2022)
5.2 Global Tuberculosis Diagnostic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Tuberculosis Diagnostic Revenue by Company (2020-2022)
6.2 North America Tuberculosis Diagnostic Revenue by Type (2017-2028)
6.3 North America Tuberculosis Diagnostic Revenue by Application (2017-2028)
6.4 North America Tuberculosis Diagnostic Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Tuberculosis Diagnostic Revenue by Company (2020-2022)
7.2 Europe Tuberculosis Diagnostic Revenue by Type (2017-2028)
7.3 Europe Tuberculosis Diagnostic Revenue by Application (2017-2028)
7.4 Europe Tuberculosis Diagnostic Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Tuberculosis Diagnostic Revenue by Company (2020-2022)
8.2 Asia Pacific Tuberculosis Diagnostic Revenue by Type (2017-2028)
8.3 Asia Pacific Tuberculosis Diagnostic Revenue by Application (2017-2028)
8.4 Asia Pacific Tuberculosis Diagnostic Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Tuberculosis Diagnostic Revenue by Company (2020-2022)
9.2 Latin America Tuberculosis Diagnostic Revenue by Type (2017-2028)
9.3 Latin America Tuberculosis Diagnostic Revenue by Application (2017-2028)
9.4 Latin America Tuberculosis Diagnostic Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Tuberculosis Diagnostic Revenue by Company (2020-2022)
10.2 Middle East and Africa Tuberculosis Diagnostic Revenue by Type (2017-2028)
10.3 Middle East and Africa Tuberculosis Diagnostic Revenue by Application (2017-2028)
10.4 Middle East and Africa Tuberculosis Diagnostic Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Tuberculosis Diagnostic Products and Services
11.1.4 Thermo Fisher Scientific Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022)
11.1.5 Thermo Fisher Scientific Tuberculosis Diagnostic SWOT Analysis
11.1.6 Thermo Fisher Scientific Recent Developments
11.2 Hologic Corporation
11.2.1 Hologic Corporation Company Details
11.2.2 Hologic Corporation Business Overview
11.2.3 Hologic Corporation Tuberculosis Diagnostic Products and Services
11.2.4 Hologic Corporation Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022)
11.2.5 Hologic Corporation Tuberculosis Diagnostic SWOT Analysis
11.2.6 Hologic Corporation Recent Developments
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Tuberculosis Diagnostic Products and Services
11.3.4 Abbott Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022)
11.3.5 Abbott Tuberculosis Diagnostic SWOT Analysis
11.3.6 Abbott Recent Developments
11.4 Becton Dickinson
11.4.1 Becton Dickinson Company Details
11.4.2 Becton Dickinson Business Overview
11.4.3 Becton Dickinson Tuberculosis Diagnostic Products and Services
11.4.4 Becton Dickinson Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022)
11.4.5 Becton Dickinson Tuberculosis Diagnostic SWOT Analysis
11.4.6 Becton Dickinson Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Tuberculosis Diagnostic Products and Services
11.5.4 Roche Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022)
11.5.5 Roche Tuberculosis Diagnostic SWOT Analysis
11.5.6 Roche Recent Developments
11.6 bioMerieux
11.6.1 bioMerieux Company Details
11.6.2 bioMerieux Business Overview
11.6.3 bioMerieux Tuberculosis Diagnostic Products and Services
11.6.4 bioMerieux Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022)
11.6.5 bioMerieux Tuberculosis Diagnostic SWOT Analysis
11.6.6 bioMerieux Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Tuberculosis Diagnostic Products and Services
11.7.4 Sanofi Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022)
11.7.5 Sanofi Tuberculosis Diagnostic SWOT Analysis
11.7.6 Sanofi Recent Developments
11.8 Cepheid
11.8.1 Cepheid Company Details
11.8.2 Cepheid Business Overview
11.8.3 Cepheid Tuberculosis Diagnostic Products and Services
11.8.4 Cepheid Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022)
11.8.5 Cepheid Tuberculosis Diagnostic SWOT Analysis
11.8.6 Cepheid Recent Developments
11.9 Hain Lifescience
11.9.1 Hain Lifescience Company Details
11.9.2 Hain Lifescience Business Overview
11.9.3 Hain Lifescience Tuberculosis Diagnostic Products and Services
11.9.4 Hain Lifescience Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022)
11.9.5 Hain Lifescience Tuberculosis Diagnostic SWOT Analysis
11.9.6 Hain Lifescience Recent Developments
11.10 QIAGEN
11.10.1 QIAGEN Company Details
11.10.2 QIAGEN Business Overview
11.10.3 QIAGEN Tuberculosis Diagnostic Products and Services
11.10.4 QIAGEN Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022)
11.10.5 QIAGEN Tuberculosis Diagnostic SWOT Analysis
11.10.6 QIAGEN Recent Developments
12 Tuberculosis Diagnostic Market Dynamics
12.1 Tuberculosis Diagnostic Market Trends
12.2 Tuberculosis Diagnostic Market Drivers
12.3 Tuberculosis Diagnostic Market Challenges
12.4 Tuberculosis Diagnostic Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of TablesTable 1. Global Tuberculosis Diagnostic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Radiographic Method
Table 3. Key Players of Diagnostic Laboratory Methods
Table 4. Key Players of Nucleic Acid Testing
Table 5. Key Players of Phage Assay
Table 6. Key Players of Detection of Latent Infection
Table 7. Key Players of Cytokine Detection Assay
Table 8. Key Players of Detection of Drug Resistance
Table 9. Global Tuberculosis Diagnostic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 10. Global Tuberculosis Diagnostic Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 11. Global Tuberculosis Diagnostic Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Tuberculosis Diagnostic Revenue Market Share by Region (2017-2022)
Table 13. Global Tuberculosis Diagnostic Revenue by Players (2017-2022) & (US$ Million)
Table 14. Global Tuberculosis Diagnostic Market Share by Players (2017-2022)
Table 15. Global Top Tuberculosis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnostic as of 2021)
Table 16. Ranking of Global Top Tuberculosis Diagnostic Companies by Revenue (US$ Million) in 2021
Table 17. Global 5 Largest Players Market Share by Tuberculosis Diagnostic Revenue (CR5 and HHI) & (2017-2022)
Table 18. Key Players Headquarters and Area Served
Table 19. Key Players Tuberculosis Diagnostic Product Solution and Service
Table 20. Date of Key Manufacturers Enter into Tuberculosis Diagnostic Market
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Tuberculosis Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 23. Global Tuberculosis Diagnostic Revenue Market Share by Type (2017-2022)
Table 24. Global Tuberculosis Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 25. Global Tuberculosis Diagnostic Revenue Market Share by Type (2023-2028)
Table 26. Global Tuberculosis Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 27. Global Tuberculosis Diagnostic Revenue Market Share by Application (2017-2022)
Table 28. Global Tuberculosis Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 29. Global Tuberculosis Diagnostic Revenue Market Share by Application (2023-2028)
Table 30. North America Tuberculosis Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 31. North America Tuberculosis Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 32. North America Tuberculosis Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 33. North America Tuberculosis Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 34. North America Tuberculosis Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 35. North America Tuberculosis Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 36. North America Tuberculosis Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 37. Europe Tuberculosis Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 38. Europe Tuberculosis Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 39. Europe Tuberculosis Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 40. Europe Tuberculosis Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 41. Europe Tuberculosis Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 42. Europe Tuberculosis Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 43. Europe Tuberculosis Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Tuberculosis Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 45. Asia Pacific Tuberculosis Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Tuberculosis Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Tuberculosis Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Tuberculosis Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Tuberculosis Diagnostic Revenue by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Tuberculosis Diagnostic Revenue by Region (2023-2028) & (US$ Million)
Table 51. Latin America Tuberculosis Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 52. Latin America Tuberculosis Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 53. Latin America Tuberculosis Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 54. Latin America Tuberculosis Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 55. Latin America Tuberculosis Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 56. Latin America Tuberculosis Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 57. Latin America Tuberculosis Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Tuberculosis Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 59. Middle East and Africa Tuberculosis Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Tuberculosis Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Tuberculosis Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Tuberculosis Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Tuberculosis Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Tuberculosis Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 65. Thermo Fisher Scientific Company Details
Table 66. Thermo Fisher Scientific Business Overview
Table 67. Thermo Fisher Scientific Tuberculosis Diagnostic Product and Services
Table 68. Thermo Fisher Scientific Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022) & (US$ Million)
Table 69. Thermo Fisher Scientific Tuberculosis Diagnostic SWOT Analysis
Table 70. Thermo Fisher Scientific Recent Developments
Table 71. Hologic Corporation Company Details
Table 72. Hologic Corporation Business Overview
Table 73. Hologic Corporation Tuberculosis Diagnostic Product and Services
Table 74. Hologic Corporation Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022) & (US$ Million)
Table 75. Hologic Corporation Tuberculosis Diagnostic SWOT Analysis
Table 76. Hologic Corporation Recent Developments
Table 77. Abbott Company Details
Table 78. Abbott Business Overview
Table 79. Abbott Tuberculosis Diagnostic Product and Services
Table 80. Abbott Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022) & (US$ Million)
Table 81. Abbott Tuberculosis Diagnostic SWOT Analysis
Table 82. Abbott Recent Developments
Table 83. Becton Dickinson Company Details
Table 84. Becton Dickinson Business Overview
Table 85. Becton Dickinson Tuberculosis Diagnostic Product and Services
Table 86. Becton Dickinson Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022) & (US$ Million)
Table 87. Becton Dickinson Tuberculosis Diagnostic SWOT Analysis
Table 88. Becton Dickinson Recent Developments
Table 89. Roche Company Details
Table 90. Roche Business Overview
Table 91. Roche Tuberculosis Diagnostic Product and Services
Table 92. Roche Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022) & (US$ Million)
Table 93. Roche Tuberculosis Diagnostic SWOT Analysis
Table 94. Roche Recent Developments
Table 95. bioMerieux Company Details
Table 96. bioMerieux Business Overview
Table 97. bioMerieux Tuberculosis Diagnostic Product and Services
Table 98. bioMerieux Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022) & (US$ Million)
Table 99. bioMerieux Tuberculosis Diagnostic SWOT Analysis
Table 100. bioMerieux Recent Developments
Table 101. Sanofi Company Details
Table 102. Sanofi Business Overview
Table 103. Sanofi Tuberculosis Diagnostic Product and Services
Table 104. Sanofi Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022) & (US$ Million)
Table 105. Sanofi Tuberculosis Diagnostic SWOT Analysis
Table 106. Sanofi Recent Developments
Table 107. Cepheid Company Details
Table 108. Cepheid Business Overview
Table 109. Cepheid Tuberculosis Diagnostic Product and Services
Table 110. Cepheid Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022) & (US$ Million)
Table 111. Cepheid Tuberculosis Diagnostic SWOT Analysis
Table 112. Cepheid Recent Developments
Table 113. Hain Lifescience Company Details
Table 114. Hain Lifescience Business Overview
Table 115. Hain Lifescience Tuberculosis Diagnostic Product and Services
Table 116. Hain Lifescience Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022) & (US$ Million)
Table 117. Hain Lifescience Tuberculosis Diagnostic SWOT Analysis
Table 118. Hain Lifescience Recent Developments
Table 119. QIAGEN Company Details
Table 120. QIAGEN Business Overview
Table 121. QIAGEN Tuberculosis Diagnostic Product and Services
Table 122. QIAGEN Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022) & (US$ Million)
Table 123. QIAGEN Tuberculosis Diagnostic SWOT Analysis
Table 124. QIAGEN Recent Developments
Table 125. Tuberculosis Diagnostic Market Trends
Table 126. Tuberculosis Diagnostic Market Drivers
Table 127. Tuberculosis Diagnostic Market Challenges
Table 128. Tuberculosis Diagnostic Market Restraints
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Tuberculosis Diagnostic Sales Market Share by Type: 2021 VS 2028
Figure 2. Radiographic Method Features
Figure 3. Diagnostic Laboratory Methods Features
Figure 4. Nucleic Acid Testing Features
Figure 5. Phage Assay Features
Figure 6. Detection of Latent Infection Features
Figure 7. Cytokine Detection Assay Features
Figure 8. Detection of Drug Resistance Features
Figure 9. Global Tuberculosis Diagnostic Sales Market Share by Application: 2021 VS 2028
Figure 10. Infants Case Studies
Figure 11. Adults Case Studies
Figure 12. Tuberculosis Diagnostic Report Years Considered
Figure 13. Global Tuberculosis Diagnostic Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Tuberculosis Diagnostic Market Size 2017-2028 (US$ Million)
Figure 15. Global Tuberculosis Diagnostic Market Size Market Share by Region: 2021 VS 2028
Figure 16. Global Tuberculosis Diagnostic Revenue Market Share by Region in 2017 VS 2022
Figure 17. Global Top 10 Tuberculosis Diagnostic Countries Ranking by Market Size (US$ Million) in 2021
Figure 18. Global Tuberculosis Diagnostic Market Share by Players in 2021
Figure 19. Global Top Tuberculosis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnostic as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Tuberculosis Diagnostic Revenue in 2021
Figure 21. North America Tuberculosis Diagnostic Revenue Market Share by Company in 2021
Figure 22. North America Tuberculosis Diagnostic Revenue Market Share by Type (2017-2028)
Figure 23. North America Tuberculosis Diagnostic Revenue Market Share by Application (2017-2028)
Figure 24. North America Tuberculosis Diagnostic Revenue Share by Country (2017-2028)
Figure 25. U.S. Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 26. Canada Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 27. Europe Tuberculosis Diagnostic Revenue Market Share by Company in 2021
Figure 28. Europe Tuberculosis Diagnostic Revenue Market Share by Type (2017-2028)
Figure 29. Europe Tuberculosis Diagnostic Revenue Market Share by Application (2017-2028)
Figure 30. Europe Tuberculosis Diagnostic Revenue Share by Country (2017-2028)
Figure 31. Germany Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 32. France Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 33. U.K. Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 34. Italy Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 35. Russia Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Tuberculosis Diagnostic Revenue Market Share by Company in 2021
Figure 37. Asia Pacific Tuberculosis Diagnostic Revenue Market Share by Type (2017-2028)
Figure 38. Asia Pacific Tuberculosis Diagnostic Revenue Market Share by Application (2017-2028)
Figure 39. Asia Pacific Tuberculosis Diagnostic Revenue Share by Region (2017-2028)
Figure 40. China Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 41. Japan Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 42. South Korea Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 43. India Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 44. Australia Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 45. Taiwan Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 46. Indonesia Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 47. Thailand Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 48. Malaysia Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 49. Philippines Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 50. Vietnam Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 51. Latin America Tuberculosis Diagnostic Revenue Market Share by Company in 2021
Figure 52. Latin America Tuberculosis Diagnostic Revenue Market Share by Type (2017-2028)
Figure 53. Latin America Tuberculosis Diagnostic Revenue Market Share by Application (2017-2028)
Figure 54. Latin America Tuberculosis Diagnostic Revenue Share by Country (2017-2028)
Figure 55. Mexico Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 56. Brazil Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 57. Argentina Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 58. Middle East and Africa Tuberculosis Diagnostic Revenue Market Share by Company in 2021
Figure 59. Middle East and Africa Tuberculosis Diagnostic Revenue Market Share by Type (2017-2028)
Figure 60. Middle East and Africa Tuberculosis Diagnostic Revenue Market Share by Application (2017-2028)
Figure 61. Middle East and Africa Tuberculosis Diagnostic Revenue Share by Country (2017-2028)
Figure 62. Turkey Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 63. Saudi Arabia Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 64. U.A.E Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 65. Thermo Fisher Scientific Revenue Growth Rate in Tuberculosis Diagnostic Business (2017-2022)
Figure 66. Hologic Corporation Revenue Growth Rate in Tuberculosis Diagnostic Business (2017-2022)
Figure 67. Abbott Revenue Growth Rate in Tuberculosis Diagnostic Business (2017-2022)
Figure 68. Becton Dickinson Revenue Growth Rate in Tuberculosis Diagnostic Business (2017-2022)
Figure 69. Roche Revenue Growth Rate in Tuberculosis Diagnostic Business (2017-2022)
Figure 70. bioMerieux Revenue Growth Rate in Tuberculosis Diagnostic Business (2017-2022)
Figure 71. Sanofi Revenue Growth Rate in Tuberculosis Diagnostic Business (2017-2022)
Figure 72. Cepheid Revenue Growth Rate in Tuberculosis Diagnostic Business (2017-2022)
Figure 73. Hain Lifescience Revenue Growth Rate in Tuberculosis Diagnostic Business (2017-2022)
Figure 74. QIAGEN Revenue Growth Rate in Tuberculosis Diagnostic Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed